Trial Profile
Antibody response in healthcare workers vaccinated with live-attenuated recombinant Japanese encephalitis chimeric vaccine
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2016
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 19 Sep 2016 New trial record